Related Experiment Video
Updated: Sep 20, 2025

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Arrhythmic mitral valve prolapse: In which patients should primary prevention of sudden cardiac death be considered
Juan M Iroulart1, Rocío Blanco1, Ana L Miceli1
1Cardiology Department, Hospital Italiano de Buenos Aires, Argentina.
Abstract:
Mitral valve prolapse (MVP) affects 2-3 % of the population and is generally benign. However, a subgroup presents severe complications such as ventricular arrhythmias and sudden cardiac death (SCD). Arrhythmogenic mitral valve prolapse (AMVP) combines MVP with frequent or complex ventricular arrhythmias in the absence of other causes. Although SCD in AMVP patients is rare (0.2-0.4 %, annual), it exceeds the general population rate and is associated with specific high arrhythmic risk features, such as mitral annular disjunction (MAD), bileaflet prolapse, Pickelhaube sign, abnormal T waves on the electrocardiogram, and rapid non-sustained ventricular tachycardia. Primary prevention is crucial but challenged by the lack of standardized guidelines. AMVP requires a multidisciplinary and cost-effective evaluation to stratify risk and prevent SCD in a predominantly young and healthy population. The objective of this review is to describe the variables with the highest arrhythmogenic risk in patients with MVP and the possible primary prevention strategies for sudden cardiac death.
Insights
Arrhythmogenic mitral valve prolapse (AMVP) carries a rare but elevated risk of sudden cardiac death (SCD). Identifying high-risk features like mitral annular disjunction is key for primary prevention strategies.
Area of Science:
- Cardiology
- Cardiac Electrophysiology
Background:
- Mitral valve prolapse (MVP) is common, yet a subset develops serious complications including ventricular arrhythmias and sudden cardiac death (SCD).
- Arrhythmogenic mitral valve prolapse (AMVP) specifically links MVP with significant ventricular arrhythmias without other identifiable causes.
Purpose of the Study:
- To identify key variables associated with the highest arrhythmogenic risk in patients with MVP.
- To explore primary prevention strategies aimed at mitigating sudden cardiac death (SCD) in this population.
Main Methods:
- This review synthesizes current literature on arrhythmogenic mitral valve prolapse (AMVP).
- It focuses on identifying specific clinical, echocardiographic, and electrocardiographic features indicative of high arrhythmic risk.
Main Results:
- Specific risk factors for SCD in AMVP include mitral annular disjunction (MAD), bileaflet prolapse, and specific ECG abnormalities.
- While SCD is rare (0.2-0.4% annually), the risk is notably higher than in the general population.
Conclusions:
- AMVP necessitates a focused, multidisciplinary approach for accurate risk stratification.
- Standardized guidelines for primary prevention of SCD in AMVP patients are critically needed, especially given the affected demographic is often young.
More Related Videos
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Valve Prolapse II: Assessment and Management
Mitral Valve Prolapse III: Nursing Management
Mitral Valve Prolapse I: Introduction
Mitral Regurgitation III: Medical Management
Mitral Stenosis IV: Nursing Management

